These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6136281)

  • 1. Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study.
    Seyfried CA
    Biochem Pharmacol; 1983 Aug; 32(15):2329-31. PubMed ID: 6136281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative biochemical and behavioural effects of fencamfamine and dl-amphetamine in rats.
    Aizenstein ML; Scavone C; Bernardi MM; Delucia R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):187-94. PubMed ID: 6684314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization.
    Aizenstein ML; Segal DS; Kuczenski R
    Neuropsychopharmacology; 1990 Aug; 3(4):283-90. PubMed ID: 1976010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices.
    DeLucia R; Planeta CS; Ferreira MP; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1997 May; 30(5):637-40. PubMed ID: 9283632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different roles for type A and type B monoamine oxidase in regulating synaptic dopamine at D-1 and D-2 receptors associated with adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation.
    Liccione J; Azzaro AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):151-8. PubMed ID: 2835690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties and schedule effects of fencamfamine in rats.
    Risner ME; Jackson-Smith PA; Cone EJ
    Pharmacol Biochem Behav; 1985 Sep; 23(3):449-56. PubMed ID: 2864703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of central stimulation action of fencamfamine.
    DeLucia R; Bernardi MM; Scavone C; Aizenstein ML
    Gen Pharmacol; 1984; 15(5):407-10. PubMed ID: 6150875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apomorphine on rat motor activity induced by fencamfamine and other indirect psychostimulant drugs.
    Aizenstein ML; da-Silva-Planeta C; DeLucia R; da-Silva CS
    Braz J Med Biol Res; 1995 Sep; 28(9):995-8. PubMed ID: 8580889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
    Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic treatment with fencamfamine on body weight, food intake and stereotyped behaviour in rats.
    DeLucia R; Aizenstein ML; Scavone C; Planeta Cda S
    Gen Pharmacol; 1987; 18(3):299-301. PubMed ID: 2883072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fencamfamine on single unit activity of mesencephalic dopaminergic neurons in rats.
    Matthews RT
    J Neural Transm; 1988; 71(1):45-55. PubMed ID: 3343595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time resolved dopamine overflow from synaptosomes and chopped striatal tissue with rapid superfusion.
    Kristensen EW; Bigelow JC; Wightman RM
    Brain Res; 1988 Sep; 461(1):44-52. PubMed ID: 3224276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of long-term administration of fencamfamine: neurochemical implications.
    Planeta CS; Scavone C; De Lucia R; Aizenstein ML
    Gen Pharmacol; 1987; 18(4):347-9. PubMed ID: 3609692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.